What Know About Orbimed's Influence on Enliven's 130% Rally
A major share sale by Orbimed Advisors in Enliven Therapeutics coincides with a sharp stock rally. This guide breaks ...
Understand the step-by-step process of refinancing with a concise overview of what happens at each stage.
15,155 articlesA major share sale by Orbimed Advisors in Enliven Therapeutics coincides with a sharp stock rally. This guide breaks ...
A fresh AI marketing platform is launching via Reg A+ at 0.85 per share, aiming to deliver rapid ROI for large brands...
A rapid shift is redefining tech leadership along a coastal corridor from NYC to Miami. The next great american tech ...
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Lawmakers push for AI safety, privacy, and energy rules. Investors weigh how regulation could affect big AI players a...
D-Wave Quantum spiked on news of fresh government funding but ended lower as bulls and bears debated quantum advantag...
A domestic sting underscores how easily scams prey on seniors. Explore how the scheme worked, the red flags to watch ...
A forward-looking look at Compugen's 2025 earnings. Learn how pipeline progress, partnerships, and cash runway could ...
Variant has closed a $222 million fund to back early-stage startups at the intersection of AI, crypto, and autonomy. ...
A leading venture figure signals a six-day, in-office funding filter, prompting founders to rethink work arrangements...
Polychain Capital has secured a $200 million first close for its fourth crypto fund, with plans to reach roughly $400...
In May, nano nuclear energy powered stocks surged as collaborations with data centers and regulatory progress lifted ...